On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Key concepts
- Glossary of terms
- Alcohol-associated mortality
- Alcohol-related liver deaths in the UK
- Price of alcohol to income ratio & consumption
- Consequences of excess alcohol consumption
- Alcoholism is a clandestine disorder
- Subjects with alcohol dependence
- CAGE questions
- Factors of development of alcoholic liver disease
- Histology of alcoholic liver disease
- The mechanism of alcoholic liver disease
- How strong is the urge to drink alcohol?
- Divert study
- Does abstinence matter?
- Survival and alcohol use vs. abstinence
- Psychotherapy for alcoholism
- Pharmacotherapy of alcoholism
- Pharmacotherapy for alcoholic hepatitis (1)
- Survival in three randomized controlled trials
- Pharmacotherapy for alcoholic hepatitis (2)
- Pentoxifylline improves short-term survival
- Infliximab in severe alcoholic hepatitis
- Etanercept and alcoholic hepatitis
- Liver transplantation in severe alcoholic hepatitis
- Pharmacotherapy for alcoholic fibrosis/cirrhosis
- Decompensated alcoholic liver disease
- Survival after liver transplantation
- Prognostic factors for increased risk of relapse
- Does relapse matter?
- Consequences of relapse after transplantation
- Key concepts - summary
Topics Covered
- Alcoholism, including the toll of alcoholism, is key to understanding alcoholic liver disease (ALD)
- Alcoholism is clandestine disorder
- Abstinence is key to recovery from both alcoholism and ALD
- There are few evidence-based therapies for ALD, other than abstinence
- Liver transplantation is valuable in selected subjects with ALD
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lucey, M. (2011, January 5). Alcoholic liver disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/QQGY9647.Export Citation (RIS)
Publication History
- Published on January 5, 2011
Financial Disclosures
- Prof. Michael Lucey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.